SEPTEMBER 19, 2019 / BY NANCY CROTTI
Globus Medical (NYSE:GMED) has acquired most of the assets of privately held orthopedics manufacturer StelKast for $24.1 million.
The purchase price could increase by $4.3 million if certain product and sales milestones are met, including a robot-assisted system for joint reconstruction expected to launch in late 2020.
McMurray, Penn.-based StelKast designs, manufactures and distributes implants and instruments for knee and hip replacement. The acquisition could help Globus (Audubon, Penn.) expand into the total joint and arthroplasty markets, according to Globus.
